NCT00244231View on ClinicalTrials.gov

Efficacy and Safety Study of Nidadd in the Management of Hyperlipidemia

PHASE3CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

October 31, 2003

Study Completion Date

August 31, 2005

Conditions
Hyperlipidemia
Interventions
DRUG

Nidadd

Sponsors
All Listed Sponsors
lead

Genovate Biotechnology Co., Ltd.,

INDUSTRY